2014•Biomedical Research-tokyoRequires access

Dyslipidemia and its correlation with type 2 diabetic patients at differentstages of proteinuria.

Noura Al‐Jameil, Farah Aziz Khan, Sadia Arjum, Mohammad Fareed Khan, Hajera Tabassum

Open publisher page 5 citations

Abstract

Diabetic nephropathy is the consequence of diabetes mellitus (DM) and it is characterized by continuous albuminuria. The aim of the study was to investigate and correlate the lipid profile abnormalities in different stages of albuminuria to understand the checkpoint before progression to end stage renal disease (ESRD). A total of 154 type 2 diabetic patients were included in the study. Urine samples of all patients were subject to biochemical analysis and divided into diabetes with normoalbuminuria (n=52), diabetes with microalbuminuria (n=51), and diabetes with overt proteinuria (n=51) groups, depending upon urinary albumin creatinine ratio (ACR) of 300 mg/24 hours respectively. Statistical analysis was done by using One Way ANOVA and Pearson’s correlation coefficient. All lipid profile parameters, such as total cholesterol (TC), triglycerides (Tg), low density lipoprotein (LDL), very low density lipoprotein (VLDL) mean values except high density lipoprotein cholesterol (HDL-C) were increased in all the three groups i.e. diabetes with normoalbuminuria, diabetes with microalbuminuria, diabetes with overt proteinuria, were significantly increased at P<0.005 and found to be in positive correlation with ACR. Dyslipidemia concurrently with microalbuminuria should be considered as alarming signal for both cardiovascular disease (CVD) and ESRD. Therefore, detection of dyslipidemia with a corresponding microalbuminuria in the beginning of DM and accordingly therapeutic intervention could control the resulting cardiovascular or renal complications.

About this research paper

What this paper is about

Diabetic nephropathy is the consequence of diabetes mellitus (DM) and it is characterized by continuous albuminuria. The aim of the study was to investigate and correlate the lipid profile abnormalities in different stages of albuminuria to understand the checkpoint before progression to end stage renal disease (ESRD). A total of 154 type 2 diabetic patients were included in the study. Urine samples of all patients were subject to biochemical analysis and divided into diabetes with normoalbuminuria (n=52), diabetes with microalbuminuria (n=51), and diabetes with overt proteinuria (n=51) groups, depending upon urinary albumin creatinine ratio (ACR) of 300 mg/24 hours respectively. Statistical analysis was done by using One Way ANOVA and Pearson’s correlation coefficient. All lipid profile parameters, such as total cholesterol (TC), triglycerides (Tg), low density lipoprotein (LDL), very low density lipoprotein (VLDL) mean values except high density lipoprotein cholesterol (HDL-C) were increased in all the three groups i.e. diabetes with normoalbuminuria, diabetes with microalbuminuria, diabetes with overt proteinuria, were significantly increased at P<0.005 and found to be in positive correlation with ACR. Dyslipidemia concurrently with microalbuminuria should be considered as alarming signal for both cardiovascular disease (CVD) and ESRD. Therefore, detection of dyslipidemia with a corresponding microalbuminuria in the beginning of DM and accordingly therapeutic intervention could control the resulting cardiovascular or renal complications.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Diabetic nephropathy is the consequence of diabetes mellitus (DM) and it is characterized by continuous albuminuria. The aim of the study was to investigate and correlate the lipid profile abnormalities in different stages of albuminuria to understand the checkpoint before progression to end stage renal disease (ESRD). A total of 154 type 2 diabetic patients were included in the study. Urine samples of all patients were subject to biochemical analysis and divided into diabetes with normoalbuminuria (n=52), diabetes with microalbuminuria (n=51), and diabetes with overt proteinuria (n=51) groups, depending upon urinary albumin creatinine ratio (ACR) of 300 mg/24 hours respectively. Statistical analysis was done by using One Way ANOVA and Pearson’s correlation coefficient. All lipid profile parameters, such as total cholesterol (TC), triglycerides (Tg), low density lipoprotein (LDL), very low density lipoprotein (VLDL) mean values except high density lipoprotein cholesterol (HDL-C) were increased in all the three groups i.e. diabetes with normoalbuminuria, diabetes with microalbuminuria, diabetes with overt proteinuria, were significantly increased at P<0.005 and found to be in positive correlation with ACR. Dyslipidemia concurrently with microalbuminuria should be considered as alarming signal for both cardiovascular disease (CVD) and ESRD. Therefore, detection of dyslipidemia with a corresponding microalbuminuria in the beginning of DM and accordingly therapeutic intervention could control the resulting cardiovascular or renal complications.

Key concepts: Microalbuminuria, Dyslipidemia, Albuminuria, Medicine, Internal medicine, Diabetes mellitus, Diabetic nephropathy, Proteinuria

Related papers

Back to paper searchBrowse research topicsOriginal source
Dyslipidemia and its correlation with type 2 diabetic patients at differentstages of proteinuria. — Research Paper | ScholarLens